KDDI, Sony and existing investor Liberty Media helped the passwordless authentication system developer close its first round since 2017.

Wix.com was among the investors in a $50m first close of the online lender's series B round, following $105m in series A funding closed in 2018.

Novo and Pivotal BioVenture Partners both invested as the lung disease therapy developer took its overall funding close to $100m.

Otsuka Pharmaceuticals's McQuade Center for Strategic Research and Development backed the psilocybin-based mental health drug developer through the round.

The digital life insurer has revealed it closed a series B round in February that included Sammons Financial to increase its total funding to more than $67m.

GV led a series B round for Digits that was disclosed as it publicly launched its business expenditure analysis software, four months after its series A.

The retail group returned to take part in a series B round that will find the expansion of chickpea-based protein developer InnovoPro's production capacity.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

CAS Star has led a $14.1m round for the semiconductor production equipment maker that will fund hiring and product development.

GV, AbbVie Ventures and NS Investment have contributed to a series B round for the oncology drug developer, which has now raised a total of $103m.